Private equity
We work with private equity firms and portfolio leadership teams navigating growth, integration, and inflection points across B2B health and research.
Brand is not cosmetic in these moments. It is structural. When positioning drifts or alignment weakens, value erodes quietly.
How we think
Clarity under pressure
In high-velocity environments shaped by automation, AI, and compressed timelines, speed alone does not create value. Judgment does.
Value is built when leadership is clear on positioning, aligned on direction, and disciplined in execution.
Knowing where to apply pressure. Where to pause. And where alignment must be exact for the structure to hold.
This perspective shapes how we approach diagnostics, strategic resets, and full rebrands in PE-backed health and research companies.
Where this work shows up
We support sponsors and portfolio leadership teams at moments when clarity directly impacts enterprise value:
check_small Pre-acquisition or diligence
check_small Post-acquisition integration
check_small Strategic resets after rapid growth
check_small Rebrands ahead of expansion or exit
check_small Alignment interventions when momentum slows
Engagements may begin with a Brand Value Risk Scan, Brand Alignment Scan, Brand Strategy Reset, or 9-Lenses Workshop, and evolve into a full strategic rebrand aligned to the investment thesis.
Insights
Insights for Private Equity Leaders
Brand clarity is a strategic asset in PE-backed B2B health organizations navigating M&A, leadership transitions, and AI-driven competitive pressure.
Drawing on decades of experience inside these companies, Orange Square examines how rebranding stabilizes organizations, accelerates growth, and protects enterprise value.If you’re navigating a moment where brand clarity intersects with value creation, we’re happy to have a working conversation.